Basit öğe kaydını göster

Safety profile of BG00012, all oral formulation of dimethyl fumarate for patients with relapsing MS

dc.contributor.authorKappos, Ludwig
dc.contributor.authorMiller, David H.
dc.contributor.authorHavrdova, Eva
dc.contributor.authorLimmroth, Volker
dc.contributor.authorPolman, Chris
dc.contributor.authorERAKSOY, Mefküre
dc.contributor.authorMeluzinova, Eva
dc.contributor.authorRektor, Ivan
dc.contributor.authorYang, Minhua
dc.contributor.authorMorganroth, Joel
dc.contributor.authorLunde, Norman Martin
dc.contributor.authorDawson, Kate
dc.contributor.authorO'Neill, Gilmore N.
dc.contributor.authorGold, Ralf
dc.date.accessioned2022-02-18T08:52:40Z
dc.date.available2022-02-18T08:52:40Z
dc.identifier.citationGold R., Kappos L., Miller D. H. , Havrdova E., Limmroth V., Polman C., ERAKSOY M., Meluzinova E., Rektor I., Yang M., et al., "Safety profile of BG00012, all oral formulation of dimethyl fumarate for patients with relapsing MS", 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, Montreal, Kanada, 17 - 20 Eylül 2008, cilt.14
dc.identifier.othervv_1032021
dc.identifier.otherav_0314388e-30c1-48cb-bca4-d92f6c7218c4
dc.identifier.urihttp://hdl.handle.net/20.500.12627/176026
dc.language.isoeng
dc.subjectHealth Sciences
dc.subjectNeurology (clinical)
dc.subjectKLİNİK NEUROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectNEUROSCIENCES
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectNeurology
dc.subjectDevelopmental Neuroscience
dc.subjectCellular and Molecular Neuroscience
dc.subjectCognitive Neuroscience
dc.subjectGeneral Neuroscience
dc.subjectNeuroscience (miscellaneous)
dc.subjectSensory Systems
dc.subjectHuman-Computer Interaction
dc.subjectPhysical Sciences
dc.subjectLife Sciences
dc.titleSafety profile of BG00012, all oral formulation of dimethyl fumarate for patients with relapsing MS
dc.typeBildiri
dc.contributor.departmentRuhr University Bochum , ,
dc.identifier.volume14
dc.contributor.firstauthorID3376124


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster